Two thingsFirst Aducanumab advancing keeps the spotlight on toxic oligomers as the driver of Alzheimer’s. Clearly that’s what seems indicated, and what PMN believes. Makes sense for them to cheerlead although not obvious if anyone is noticing.
Second, it will be very interesting to see how quickly PMN can utilize their predictive algorithms to generate sensitive serology tests for CV19.
The analogy of war for this pandemic is accurate on a couple of fronts. Cost becomes irrelevant in a war, it’s about survival. Also the first casualty is truth. There is such a dearth of useful data. How many false positives will be reported from serology tests that are not able to distinguish between common cold corona virus antibodies and CV 19 antibodies. Public policy driven from unreliable data is just scary. Love to see a made in Canada test that is accepted internationally.
Frans